SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-189539
Filing Date
2018-06-11
Accepted
2018-06-11 16:54:37
Documents
5
Period of Report
2018-03-28
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d604112d8ka.htm 8-K/A 25331
2 EX-23.1 d604112dex231.htm EX-23.1 2009
3 EX-99.2 d604112dex992.htm EX-99.2 132575
4 EX-99.3 d604112dex993.htm EX-99.3 201748
5 EX-99.4 d604112dex994.htm EX-99.4 127100
  Complete submission text file 0001193125-18-189539.txt   490133
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 000-51122 | Film No.: 18892575
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10